Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ciurea, Stefan O  [Clear All Filters]
2019
Chamoun, K., Milton, D.R., Ledesma, C., Young, K.H., Jabbour, E.J., Alatrash, G., Anderlini, P., Bashir, Q., Ciurea, S.O., Marin, D., et al. (2019). Allogeneic Transplantation after Myeloablative Rituximab/BEAM +/- Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-up Results.Biol Blood Marrow Transplant.
Ciurea, S.O., Hansrivijit, P., Ciurea, A.M., Hymes, S., Chen, J., Rondon, G., Hosing, C., Popat, U., and Champlin, R.E. (2019). Curative Potential of Hematopoietic Stem Cell Transplantation for Advanced Psoriasis.Am J Hematol.
Srour, S.A., Saliba, R.M., Bittencourt, M.Cb, Perez, J.Miguel Ram, Kongtim, P., Alousi, A., Al-Atrash, G., Olson, A., Betul, O., Mehta, R., et al. (2019). Haploidentical Transplantation for Acute Myeloid Leukemia Patients with Minimal/ Measurable Residual Disease at Transplantation.Am J Hematol.
Saini, N.Y., Saliba, R.M., Rondon, G., Maadani, F., Popat, U., Hosing, C.M., Betul, O., Bashir, Q., Olson, A., Nieto, Y., et al. (2019). Impact of Donor Type and Melphalan Dose on Allogeneic Transplant Outcomes for Patients with Lymphoma.Biol Blood Marrow Transplant.
Kongtim, P., Hasan, O., Perez, J.Miguel Ram, Varma, A., Wang, S.A., Patel, K.P., Chen, J., Rondon, G., Srour, S., Bashir, Q., et al. (2019). A Novel Disease Risk Model for Patients with AML Receiving Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant.